2[1]Di-Marco V, Lo-Lacono O,Camma C et al. The long-term course of chronic hepatitia B. Hepatology, 1999,30 (1) : 257
3[2]Kage M, Shimamatu K, Naskashima E et al. Long-term evolution of fibrosis from chronic hepatitis to cirrhosis in patients with hepatitis C: morphometric analysis of repeated biopsies. Hepatology,1997,25(4) :1 028
4[3]Poynard T,Bedossa P, Opolon P et al. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet,1997,349(9055) :825
5[4]Bellentani S, Pozzato G, Saccoccio G et al. Clinical course and risk factors of hepatitis C virus related liver disease in the general population: report from the dionysos study. Gut, 1999,44 (6):874
6[5]Roudot-Thoraval F, Bastie A, Pawlotsky JM et al. Epidemiological factors affecting the severity of hepatitis C virus-related liver disease:a french survey of 6664 patients. Hepatology, 1997,26(2) :485
7[6]Fattovrch G, Giustina G, Christensen E et al. Influence of hepatitis delta virus infection on morbidity and mortality in compensated cirrhosis type B. Gut,2000,46(3) :420
8[7]Mohamed-Ali Q, Elwali NE, Abdelhameed AA et al. Susceptibility to periportal (Symners) fibrosis in human schistosoma mansoni infections: evidence that intensity and duration of infection,gender,and inherited factors are critical in disease progression. Journal of Infectious Diseases, 1999,180(4): 1 298
9[8]Sorensen HT,Thulstrup AM,Blomqvist P et al. Risk of primary biliary liver cirrhosis in patients with coeliac disease:danish and swedish cohort data. Gut, 1999,44(5) :736
10[9]Aithal PG,Day CP. The natural history of histologically proved drug induced liver disease. Gut,1999,44(5):731
